We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Testicular Cancer Detected Using a Simple Sperm Sample

By LabMedica International staff writers
Posted on 07 Jun 2012
A team of scientists has found markers for testicular cancer. More...
This will enable physicians to detect the disease before it develops, via a simple sperm sample.

Discovery of the markers has made it possible to see from a simple sperm sample whether a patient will develop testicular cancer. Thus, treatment can be provided for men who would otherwise not have found the disease until much later, and a more gentle treatment can begin at an earlier stage.

This is beneficial particularly for men with testicular cancer, because they usually discover the disease in their 20s or 30s, which means they have a long life ahead of them with possible late complications from cancer treatment.

Men with poor sperm quality, in particular, those who consult the hospital because of fertility problems, are being examined to detect possible early stages of testicular cancer. According to the investigators, poor sperm quality and predisposition to testicular cancer can be traced all the way back to fetal germ-cell development.

A research team at Rigshospitalet (Copenhagen, Denmark) has developed a special scanning microscope and software, which can analyze sperm samples. The discovery has attracted much attention from colleagues abroad.

"So far, we are cooperating with researchers in Norway, Germany, and Poland, who can make use of our discovery in different ways. The equipment is expensive, so to begin with we are helping by analyzing their samples, but in the long term we would like to join up with a company that can supply a total kit for use by other researchers and physicians in different European countries," said Kristian Almstrup from the department of growth and reproduction at Rigshospitalet.

Previously, suspicion of testicular cancer meant that a patient was subjected to one or two painful biopsies, and despite a 95% survival rate, the testicular cancer diagnosis meant having to go through treatment that could be extremely hard on the body.

Related Links:
Rigshospitalet




Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.